- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Sequent Scientific Limited — Updates, 18-11-2025: Scheme of Arrangement
18-11-2025 | 10:50 pm
18-11-2025 | 10:50 pm
SeQuent and Viyash merger is now approved, forming a global animal health powerhouse. Q2 FY26 combined sales rose 16% to ₹852.1 Cr, with EBITDA surging 76% to ₹189 Cr. This accelerates growth in companion animal health and generics, leveraging strong R&D.
No comments yet. Be the first to comment!